Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlortrimetamine tablets in adult partial epilepsy (Phase II)
CTR20132658Phase 2Completed
- Sponsor
- Beijing Bolivikang Pharmaceutical Research Institute
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorpheniramine in epilepsy, sponsored by Beijing Bolivikang Pharmaceutical Research Institute. Started Jan 2014; status: completed.
02
Drugs
chlorpheniramine
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20132658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132658.